Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023

Clinical Cancer Research

Volumn 8, Issue 4, 2002, Pages 1223-1227

  Qian, Li Wu ^a   Mizumoto, Kazuhiro ^a   Urashima, Taro ^a   Nagai, Eishi ^a   Maehara, Naoki ^a   Sato, Norihiro ^a   Nakajima, Motowo ^b   Tanaka, Masao ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CGS 27023A; GELATIN; GELATINASE A; GELATINASE B; METALLOPROTEINASE INHIBITOR; UROKINASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CELL ASSAY; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; GAMMA IRRADIATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN DEGRADATION; RADIATION DOSE; RADIATION RESPONSE; ZYMOGRAPHY;

CELL DIVISION; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENZYME INHIBITORS; HUMANS; HYDROXAMIC ACIDS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES; PANCREATIC NEOPLASMS; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0036554937     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1999. CA Cancer J. Clin., 49: 8-31, 1999.
2. Niederhuber, J. E., Brennan, M. F., and Menck, H. R. The National Cancer Data Base report on pancreatic cancer. Cancer (Phila.), 76: 1671-1677, 1995.
3. Verovski, V. N., Van den Berge, D. L., Soete, G. A., Bols, B. L., and Storme, G. A. Intrinsic radiosensitivity of human pancreatic tumor cells and radiosensitising potency of the nitric oxide donor sodium nitroprusside. Br. J. Cancer, 74: 1734-1742, 1996.
4. Miller, A. C., Whittaker, T., Thibault, A., and Samid, D. Modulation of radiation response of human tumor cells by the differentiation inducers, phenylacetate and phenylbutyrate. Int. J. Radiat. Biol., 72: 211-218, 1997.
5. Ng, C. E., Banerjee, S. K., Pavliv, M., Wang, G., Raaphorst, G. P., and Aubin, R. A. p53 status, cellular recovery and cell cycle arrest as prognosticators of in vitro radiosensitivity in human pancreatic adenocarcinoma cell lines. Int. J. Radiat. Biol., 75: 1365-1376, 1999.
6. Schwartz, J. L., Murnane, J., and Weichselbaum, R. R. The contribution of DNA ploidy to radiation sensitivity in human tumour cell lines. Br. J. Cancer, 79: 744-747, 1999.
7. Wouters, B. G., Denko, N. C., Giaccia, A. J., and Brown, J. M. A p53 and apoptotic independent role for p21waf1 in tumor response to radiation therapy. Oncogene, 18: 6540-6545, 1999.
8. Plumb, M. A., Smith, G. C., Cunniffe, S. M., Jackson, S. P., and O'Neill, P. DNA-PK activation by ionizing radiation-induced DNA single-strand breaks. Int. J. Radiat. Biol., 75: 553-561, 1999.
9. Zhang, L., Mizumoto, K., Sato, N., Ogawa, T., Kusumoto, M., Niiyama, H., and Tanaka, M. Quantitative determination of apoptotic death in cultured human pancreatic cancer cells by propidium iodide and digitonin. Cancer Lett., 142: 129-137, 1999.
10. Sato, N., Maehara, N., Mizumoto, K., Nagai, E., Yasoshima, T., Hirata, K., and Tanaka, M. Telomerase activity of cultured human pancreatic carcinoma cell lines correlates with their potential for migration and invasion. Cancer (Phila.), 91: 496-504, 2001.
11. Maehara, N., Matsumoto, K., Kuba, K., Mizumoto, K., Tanaka, M., and Nakamura, T. NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells. Br. J. Cancer, 84: 864-873. 2001.
12. Wild-Bode, C., Weller, M., Rimner, A., Dichgans, J., and Wick, W. Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res., 61: 2744-2750, 2001.
13. Camphausen, K., Moses, M. A., Beecken, W. D., Khan, M. K., Folkman, J., and O'Reilly, M. S. Radiation therapy to a primary tumor accelerates metastatic growth in mice. Cancer Res., 61: 2207-2211, 2001.
14. Wang, J. L., Sun, Y., and Wu, S. γ-Irradiation induces matrix metallorpoteinase II expression in a p53-dependent manner. Mol. Carcinog., 27: 252-258, 2000.
15. DeClerck, Y. A., and Imren, S. Protease inhibitors: role and potential therapeutic use in human cancer. Eur. J. Cancer, 14: 2170-2180, 1994.
16. Zervos, E. E., Shafii, A. E., Mahmudul Haq, B. S., and Eosemurgy, A. S. Matrix metalloproteinase inhibition suppresses MMP-2 activity and activation of Panc-1 cells in vitro. J. Surg. Res., 84: 162-167, 1999.
17. Jimenez, R. E., Hartwig, W., Antoniu, B. A., Compton, C. C., Warshaw, A. L., and Fernandez-Del Castillo, C. Effect of matrix metalloproteinase inhibition on pancreatic cancer invasion and metastasis: an additive strategy for cancer control. Ann. Surg., 231: 644-654, 2000.
18. Busso, N., Masur, S. K., Lazega, D., Waxman, S., and Ossowski, L. Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J. Cell Biol., 126: 259-270, 1994.
19. Wilson, A. J., and Gibson, P. R. Role of urokinase and its receptor in basal and stimulated colonic epithelial cell migration in vitro. Gut, 47: 105-111, 2000.
20. Carriero, M. V., Del Vecchio, S., Capozzoli, M., Franco, P., Fontana, L., Zannetti, A., Botti, G., D'Aiuto, G., Salvatore, M., and Stoppelli, M. P. Urokinase receptor interacts with αvβ5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer. Cancer Res., 59: 5307-5314, 1999.
21. Rosemurgy, A., Harris, J., Langleben, A., Casper, E., Goode, S., and Rasmussen, H. Marimastat in patients with advanced pancreatic cancer: a dose-finding study. Am. J. Clin. Oncol., 22: 247-252, 1999.